Back to Journals » Journal of Hepatocellular Carcinoma » Volume 4

Open-label phase II clinical trial in 75 patients with advanced hepatocellular carcinoma receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-L

Total article views   HTML views PDF downloads Totals
26,008 Dovepress* 22,779+ 1,440 24,219
PubMed Central* 3,229 313 3,542
Totals 26,008 1,753 27,761
*Since 12 April 2017
Total mentioned Facebook Delicious Reddit Twitter Others
309 0 0 0 4 305

View citations on PubMed Central and Google Scholar